These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 28776540)
1. Value of Combining Left Atrial Diameter and Amino-terminal Pro-brain Natriuretic Peptide to the CHA2DS2-VASc Score for Predicting Stroke and Death in Patients with Sick Sinus Syndrome after Pacemaker Implantation. Mo BF; Lu QF; Lu SB; Xie YQ; Feng XF; Li YG Chin Med J (Engl); 2017 Aug; 130(16):1902-1908. PubMed ID: 28776540 [TBL] [Abstract][Full Text] [Related]
2. CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome. Svendsen JH; Nielsen JC; Darkner S; Jensen GV; Mortensen LS; Andersen HR; Heart; 2013 Jun; 99(12):843-8. PubMed ID: 23539553 [TBL] [Abstract][Full Text] [Related]
3. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation. Glotzer TV; Hellkamp AS; Lee KL; Lamas GA Can J Cardiol; 2015 Aug; 31(8):1004-11. PubMed ID: 26076964 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407 [TBL] [Abstract][Full Text] [Related]
6. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
7. CHADS Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462 [TBL] [Abstract][Full Text] [Related]
8. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA Roldán V; Rivera-Caravaca JM; Shantsila A; García-Fernández A; Esteve-Pastor MA; Vilchez JA; Romera M; Valdés M; Vicente V; Marín F; Lip GYH Ann Med; 2018 Feb; 50(1):26-34. PubMed ID: 28892413 [TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA Mu X; Qiu M; Li Y; Li Z; Qi B; Jing Z; Jing Q Clin Cardiol; 2023 Jul; 46(7):810-817. PubMed ID: 37218400 [TBL] [Abstract][Full Text] [Related]
10. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study. Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922 [TBL] [Abstract][Full Text] [Related]
11. Refining prediction of stroke in sinus node dysfunction patients without atrial fibrillation using a P-combined score: a multi-centre study. Dong H; Zhang Y; Sun D; Wang G; Zhang Q; Hidru TH; Yang Y; Wang S; Wei Y; Liu F; Zhang J; Xia Y; Yang X Eur J Prev Cardiol; 2024 Mar; 31(5):507-518. PubMed ID: 37651722 [TBL] [Abstract][Full Text] [Related]
12. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
13. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [TBL] [Abstract][Full Text] [Related]
14. CHA Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672 [TBL] [Abstract][Full Text] [Related]
15. CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation. Wei-Syun Hu ; Lin CL Lupus; 2018 Jul; 27(8):1240-1246. PubMed ID: 29554836 [TBL] [Abstract][Full Text] [Related]
16. CHA Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320 [TBL] [Abstract][Full Text] [Related]
17. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. Saliba W; Rennert G Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101 [TBL] [Abstract][Full Text] [Related]
18. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Hu WS; Lin CL Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109 [TBL] [Abstract][Full Text] [Related]
19. Investigation of Stroke Risk Factors and Prognostic Indicators in NVAF Patients with Low CHA Gao TG; Gao F; Huang WB; Cai JY; Yang HL; Xiong CC; Ruan Y; Liu SF Int Heart J; 2023; 64(6):1040-1048. PubMed ID: 38030291 [TBL] [Abstract][Full Text] [Related]
20. CHA Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]